Evidence map›Paper›PMID 36078876›Full record

ArticleJournal of clinical medicine2022

Migraine Prevention through Ketogenic Diet: More than Body Mass Composition Changes.

Mariarosaria Valente, Riccardo Garbo, Francesca Filippi, Alice Antonutti, Veronica Ceccarini, Yan Tereshko, Cherubino Di Lorenzo, Gian Luigi Gigli

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Mariarosaria ValenteClinical Neurology Unit, Santa Maria della Misericordia University Hospital, 33100 Udine, Italy.
Riccardo GarboClinical Neurology Unit, Santa Maria della Misericordia University Hospital, 33100 Udine, Italy.ORCID 0000-0002-3193-8726
Francesca FilippiClinical Neurology Unit, Santa Maria della Misericordia University Hospital, 33100 Udine, Italy.
Alice AntonuttiDepartment of Medical Area, University of Udine, 33100 Udine, Italy.
Veronica CeccariniDepartment of Clinical and Experimental Medicine, University of Florence, 50121 Florence, Italy.
Yan TereshkoClinical Neurology Unit, Santa Maria della Misericordia University Hospital, 33100 Udine, Italy.
Cherubino Di LorenzoDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome Polo Pontino, 04100 Latina, Italy.ORCID 0000-0003-0845-5694
Gian Luigi GigliClinical Neurology Unit, Santa Maria della Misericordia University Hospital, 33100 Udine, Italy.
University of Udine · ITOspedale Santa Maria della Misericordia di Udine · ITIstituto di Sociologia Internazionale di Gorizia · ITSapienza University of Rome · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ketogenic diet (KD) is gaining attention as a preventive treatment for migraine, which is sustained by many pre-clinical and clinical data. KD is also used for weight loss, and there is a relation between migraine and weight excess, but it is speculated that KD efficacy on migraine may go beyond this effect. We conducted a retrospective observational study on 23 migraine patients who received a KD and were evaluated at the baseline and then after 3 months both from a neurological and a nutritional point of view, including body mass composition analysis. We observed a reduction in monthly headache days (12.5 ± 9.5 vs. 6.7 ± 8.6; p < 0.001) and in days of acute medication intake (11.06 ± 9.37 vs. 4.93 ± 7.99; p = 0.008). We also observed a reduction in patients’ weight (73.8 ± 15.2 vs. 68.4 ± 14.6; p < 0.001) and BMI (26.9 ± 6.2 vs. 23.7 ± 8.1; p < 0.001) with a decrement of the fat mass (28.6 ± 12.5 vs. 20.6 ± 9.8; p < 0.001). Patients who responded to KD and those who did not had no differences with respect to weight or fat mass loss. These data corroborate the utilization of KD as a preventive treatment for migraine and suggest that the efficacy of such an intervention is not only due to weight or fat mass loss but probably relies on other mechanisms specific to KD.

Indexed as

headacheketogenic dietketonesketosismigraine

Identifiers

PMID36078876
PMCPMC9456603
OpenAlexW4292877915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.